About UsClinical DevelopmentPartnershipsPatients/ProvidersInvestorsPress and Media

Recent News

Stay Informed

Click to receive news alerts

Our Mission

  • To advance patient treatment in cancer
  • To apply new insights from molecular and cancer biology to understand how to improve the efficacy and safety of cancer therapies
  • To develop and commercialize a diverse portfolio of cancer drugs to address unmet medical needs

PICASSO Trial Program

A Phase III multicenter, international, randomized, double-blinded, placebo-controlled study of doxorubicin plus palifosfamide vs. doxorubicin plus placebo in patients with front-line metastatic soft tissue sarcoma. (PICASSO 3)

Open for Enrollment: Enrollment has commenced for this global Phase III randomized trial of palifosfamide in combination with doxorubicin in subjects with front-line metastatic soft-tissue sarcoma. (PICASSO 3).


Click here to learn more.
Click here for Press Release.



August 4, 2010

ZIOPHARM Oncology to Present at the Canaccord Genuity 30th Annual Global Growth Conference More

July 30, 2010

ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs More




Video Media Coverage

Businessweek article
July 23, 2007 issue
More

Businessweek article
May 5, 2008 issue
More

Forbes.com article
May 9, 2008 issue
More

ZIO-101 listed as 100 Great Investigational Drugs by R&D Directions More

ZIO-201 listed as 100 Great Investigational Drugs by R&D Directions More

Webcast Events and Presentations

The Fifth Annual JMP Securities Healthcare Conference
September 27, 2010
Click Here for More Information

Canaccord 30th Annual Growth Conference
August 11, 2010
Click Here for More Information

ZIOPHARM Oncology Palifosfamide Trial Update
July 20, 2010
Click Here for More Information

Ziopharm Oncology highlighted on CBS Radio Network and WCBS-AM Health & Well Being Report
July 19, 2010
Click Here for More Information

ZIOPHARM Oncology's 2010 Annual Shareholder Meeting
June 23, 2010
Click Here for More Information

ZIOPHARM Oncology to Present at the Jefferies 2010 Global Life Sciences Conference
June 9, 2010
Click Here for More Information

ZIOPHARM Oncology to Present at the 9th Annual Needham Healthcare Conference
June 9, 2010
Click Here for More Information

ZIOPHARM Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference
May 17, 2010
Click Here for More Information

ZIOPHARM Oncology to Present at the Ninth Annual JMP Securities Research Conference
May 11, 2010
Click Here for More Information

ZIOPHARM Oncology to Present at the 22nd Annual Roth Growth Conference
March 15, 2010
Click Here for More Information